Tag: DR LESLIE BIDI

CAB-LA Enjoys High Continuity Rates Among PrEP Users In Zimbabwe

Michael Gwarisa

By Michael Gwarisa The recently introduced long-acting cabotegravir (CAB-LA) for HIV prevention has seen more users returning to get the second dose post their first jab, with data showing that the injectable drug has recorded a continuity rate over 90% since roll out in April, 2024. Currently, the Injectable PrEP is being administered in PrEP study sites in Harare, Mature and Bulawayo and is targeting mainly groups at high risk of HIV, namely Female Sex Workers (FSW), Adolescent Girls and Young Women (AGYW) and Men who have Sex with other…

Read More

HIV+ People With Low CD4 Count Should Consult Before Getting COVID-19 Jab

Michael Gwarisa

PEOPLE living with HIV (PLHIV) who have a low CD4 count and an uncontrolled viral load have been urged to defer getting vaccinated against COVID-19 until after discussing with medical practitioners, a medical and HIV expert has said. By Michael Gwarisa CD4 cells are white blood cells that fight infection and the CD4 count is a measure of how healthy one’s immune system is when living with HIV. People Living with HIV have been listed amongst high-risk populations in the country and have also been afforded priority status under the…

Read More